CClinicalTrials.gg
CompletedNCT04784065Updated Aug 28, 2025Results posted

A Pilot Randomized Controlled Trial for Hand Osteoarthritis

An interventional study of Hand orthosis in Hand Osteoarthritis, sponsored by Baylor College of Medicine. Completed at 2 sites in United States. Per ClinicalTrials.gov, last updated 2025-08-28.

Sponsored by Baylor College of Medicine · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
33
Allocation
Randomized
Sex
All
01

Study summary

This is a study involving people receiving care at the Michael E. DeBakey VA Medical Center, Houston Texas. We are studying people who have hand osteoarthritis (the most common form of arthritis that involves the hand) and testing treatments for the condition with the hope that we can help to improve hand pain as well as limit the damage that occurs related to the arthritis. People who choose to participate, are randomly assigned to one of two treatments, both expected to be helpful.

Read the detailed description

The research will be conducted at the following location(s):

Baylor College of Medicine, Baylor St. Luke's Medical Center (BSLMC), and Michael E. DeBakey Veterans Affairs Medical Center.

Participants of this study are consented for the study, randomized into one of two treatment groups for hand osteoarthritis, both expected to improve hand symptoms. At the beginning of the study, many questionnaires, a physical exam, photographs of the hands, some x-rays, on a limited few people, and MRI will be obtained. Then the participants will be provided treatments for hand osteoarthritis based on the group wo which they were randomly assigned. One aspect of one of the treatments is viewed as experimental but the risks related to the treatment are considered to be low, so the risk-benefit ratio for participation in this study are good. We see patients in follow up more frequently during the first month, and then at 3 months and then 6 months of follow up. At the final visit, we will repeat the xrays and the MRIs.

02

Conditions studied

  • Hand Osteoarthritis
03

In context

Lead sponsor

Baylor College of Medicine is the lead sponsor of 734 studies on the registry; 110 are open to participants now.

Of its 83 completed or terminated interventional studies of FDA-regulated products, 44 (53%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Enrolled to receive medical care at the Michael E. DeBakey VA Medical Center
  • At least 3 joints affected by distal interphalangeal (DIP) nodal hand OA
  • DIP nodal hand OA will be defined as Heberden's nodes on physical exam.
  • Sufficiently severe frequent pain of at least one DIP
  • Frequent pain: pain on most days of the month for at least one month in the last year.
  • Minimum VAS pain severity of 40 on a 0 - 100 scale

Exclusion criteria

Exclusion Criteria:

  • History or current inflammatory arthritides (examples: gout, psoriatic arthritis, and rheumatoid arthritis)
  • Prior surgery on the DIP joints
  • Planned surgery for the DIP joints
  • Pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
33 participants (actual)

Study arms

  • Active comparator
    Treatment arm with control orthosis

    A resting orthosis that was modified to allow for convenient application of finger traps. A finger trap was customized to the most symptomatic DIP and any other digit that the participant requested. The participants were asked to continue the orthosis schedule for the full 24 weeks of the study. Besides the resting hand orthosis, the SOC treatment included a thermal modality, activity modification/ joint protection education, and range of motion exercises.

    Device: Hand orthosis

  • Experimental
    Treatment arm with experimental orthosis

    An identical resting hand orthosis to what the traction arm received without the finger trap modifications. The participants were asked to continue the orthosis schedule for the full 24 weeks of the study. Besides the resting hand orthosis, the SOC treatment included a thermal modality, activity modification/ joint protection education, and range of motion exercises.

    Device: Hand orthosis

Interventions

  • DeviceHand orthosis

    An orthosis applied to a hand affected by osteoarthritis with the expectation that it will improve symptoms and possibly structural progression.

06

What researchers measure

Primary outcomes

  1. Visual Analog Scale (VAS) for Pain in the More Symptomatic Hand That Includes the Most Symptomatic DIP Joint by 24 Weeks of Use of Traction Therapy With Standard of Care Treatment for Hand OA to Establish Efficacy of Traction Therapy.

    An assessment of pain intensity in a given hand. - high values are worse outcomes. Minimum score = 0 Maximum score = 100

    Time frame: 24 week follow up

  2. The Primary Structure Endpoint Will be Change in Sum of the Kellgren and Lawrence Score of All Distal InterPhalangeal Joints in the Hand That Was Placed in an Orthosis Over 24 Weeks.

    An assessment of radiographic OA severity. (high values are worse outcomes) Minimum score = 0 Maximum score = 16

    Time frame: 24 week follow up

Secondary outcomes

  1. The Functional Index for Hand Osteoarthritis (FIHOA)

    An assessment of hand function. (high values are worse outcomes) Minumum score = 0 Maximum score = 30

    Time frame: 24 week follow up

  2. The Disabilities of Arm Shoulder and Hand (DASH)

    An assessment of hand disability. (high values are worse outcomes) Minimum score = 30 Maximum score = 150

    Time frame: 24 week follow up

  3. Functional Dexterity Test

    An assessment of hand functional dexterity. (high values are worse outcomes) Measure of the number of seconds it takes for the participant to complete a series of activities. Penalty scores are assigned if the quality of the activity performed is imperfect. Minimum score = 0 Maximum score = indefinite

    Time frame: 24 week follow up

  4. Grip Strength

    An assessment of the amount of force that can be applied with grip. (low values are worse outcomes)

    Time frame: 24 week follow up

  5. Pinch Strength

    An assessment of the amount of force that can be applied with pinching between thumb and the 2nd and 3rd fingers. (low values are worse outcomes)

    Time frame: 24 week follow up

  6. The Number of DIP Joints That Exhibit Tenderness in the Study Hand

    The number of DIP joints that exhibit tenderness (dichotomously assessed - yes/no) in the study hand. (high values are worse outcomes) Minimum score = 0 Maximum score = 4

    Time frame: 24 week follow up

07

Results

Posted Aug 28, 2025

Participant flow

Participant flow — Overall Study
MilestoneTreatment Arm With Control OrthosisTreatment Arm With Experimental Orthosis
Started1716
Completed813
Not completed93

Outcome measures

PrimaryVisual Analog Scale (VAS) for Pain in the More Symptomatic Hand That Includes the Most Symptomatic DIP Joint by 24 Weeks of Use of Traction Therapy With Standard of Care Treatment for Hand OA to Establish Efficacy of Traction Therapy.

An assessment of pain intensity in a given hand. - high values are worse outcomes. Minimum score = 0 Maximum score = 100

Time frame:
24 week follow up
Reported as:
Mean · units on a scale
Visual Analog Scale (VAS) for Pain in the More Symptomatic Hand That Includes the Most Symptomatic DIP Joint by 24 Weeks of Use of Traction Therapy With Standard of Care Treatment for Hand OA to Establish Efficacy of Traction Therapy.
units on a scaleTreatment Arm With Control OrthosisTreatment Arm With Experimental Orthosis
Visual Analog Scale (VAS) for Pain in the More Symptomatic Hand That Includes the Most Symptomatic DIP Joint by 24 Weeks of Use of Traction Therapy With Standard of Care Treatment for Hand OA to Establish Efficacy of Traction Therapy.-16.1 (-31.3 to -0.8)-15.7 (-30.0 to -1.4)
PrimaryThe Primary Structure Endpoint Will be Change in Sum of the Kellgren and Lawrence Score of All Distal InterPhalangeal Joints in the Hand That Was Placed in an Orthosis Over 24 Weeks.

An assessment of radiographic OA severity. (high values are worse outcomes) Minimum score = 0 Maximum score = 16

Time frame:
24 week follow up
Reported as:
Mean · units on a scale
The Primary Structure Endpoint Will be Change in Sum of the Kellgren and Lawrence Score of All Distal InterPhalangeal Joints in the Hand That Was Placed in an Orthosis Over 24 Weeks.
units on a scaleTreatment Arm With Control OrthosisTreatment Arm With Experimental Orthosis
The Primary Structure Endpoint Will be Change in Sum of the Kellgren and Lawrence Score of All Distal InterPhalangeal Joints in the Hand That Was Placed in an Orthosis Over 24 Weeks.0 ± 00 ± 0
SecondaryThe Functional Index for Hand Osteoarthritis (FIHOA)

An assessment of hand function. (high values are worse outcomes) Minumum score = 0 Maximum score = 30

Time frame:
24 week follow up
Reported as:
Mean · units on a scale
The Functional Index for Hand Osteoarthritis (FIHOA)
units on a scaleTreatment Arm With Control OrthosisTreatment Arm With Experimental Orthosis
The Functional Index for Hand Osteoarthritis (FIHOA)0.6 (-2.9 to 4.2)-2.6 (-5.1 to -0.2)
SecondaryThe Disabilities of Arm Shoulder and Hand (DASH)

An assessment of hand disability. (high values are worse outcomes) Minimum score = 30 Maximum score = 150

Time frame:
24 week follow up
Reported as:
Mean · units on a scale
The Disabilities of Arm Shoulder and Hand (DASH)
units on a scaleTreatment Arm With Control OrthosisTreatment Arm With Experimental Orthosis
The Disabilities of Arm Shoulder and Hand (DASH)0.9 (-6.9 to 8.7)-9.9 (-17.9 to -2.0)
SecondaryFunctional Dexterity Test

An assessment of hand functional dexterity. (high values are worse outcomes) Measure of the number of seconds it takes for the participant to complete a series of activities. Penalty scores are assigned if the quality of the activity performed is imperfect. Minimum score = 0 Maximum score = indefinite

Time frame:
24 week follow up
Reported as:
Mean · seconds
Functional Dexterity Test
secondsTreatment Arm With Control OrthosisTreatment Arm With Experimental Orthosis
Functional Dexterity Test-3.8 (-11.8 to 4.3)-6.4 (-11.0 to -1.9)
SecondaryGrip Strength

An assessment of the amount of force that can be applied with grip. (low values are worse outcomes)

Time frame:
24 week follow up
Reported as:
Mean · pounds
Grip Strength
poundsTreatment Arm With Control OrthosisTreatment Arm With Experimental Orthosis
Grip Strength3.1 (-0.5 to 6.7)5.3 (1.5 to 9.1)
SecondaryPinch Strength

An assessment of the amount of force that can be applied with pinching between thumb and the 2nd and 3rd fingers. (low values are worse outcomes)

Time frame:
24 week follow up
Reported as:
Mean · pounds
Pinch Strength
poundsTreatment Arm With Control OrthosisTreatment Arm With Experimental Orthosis
Pinch Strength0.4 (-1.3 to 2.0)0.2 (-0.8 to 1.3)
SecondaryThe Number of DIP Joints That Exhibit Tenderness in the Study Hand

The number of DIP joints that exhibit tenderness (dichotomously assessed - yes/no) in the study hand. (high values are worse outcomes) Minimum score = 0 Maximum score = 4

Time frame:
24 week follow up
Reported as:
Mean · score on a scale
The Number of DIP Joints That Exhibit Tenderness in the Study Hand
score on a scaleTreatment Arm With Control OrthosisTreatment Arm With Experimental Orthosis
The Number of DIP Joints That Exhibit Tenderness in the Study Hand-0.2 (-0.7 to 0.4)-0.4 (-1.1 to 0.2)

Adverse events

Collected over 6 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Treatment Arm With Control Orthosis0/17 (0%)0/17 (0%)8/17 (47.1%)
Treatment Arm With Experimental Orthosis0/16 (0%)0/16 (0%)8/16 (50%)
Most frequent other events
Most frequent other events
EventTreatment Arm With Control OrthosisTreatment Arm With Experimental Orthosis
Discomfort from the orthosisMusculoskeletal and connective tissue disorders5/177/16
Numbness/TinglingNervous system disorders5/171/16
Skin ErythemaSkin and subcutaneous tissue disorders0/171/16
Skin blisteringSkin and subcutaneous tissue disorders0/171/16
FallNervous system disorders0/171/16
Elective surgery to repair incisional herniaEye disorders0/171/16
Thoracic spine painMusculoskeletal and connective tissue disorders1/170/16
Knee injuryMusculoskeletal and connective tissue disorders1/170/16

Baseline characteristics

Age, Continuous
Age, Continuous(Years)Treatment Arm With Control OrthosisTreatment Arm With Experimental OrthosisTotal
Mean66.5 ± 7.165.2 ± 6.665.8 ± 6.7
Sex: Female, Male
Sex: Female, Male(Participants)Treatment Arm With Control OrthosisTreatment Arm With Experimental OrthosisTotal
Female10616
Male71017
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Treatment Arm With Control OrthosisTreatment Arm With Experimental OrthosisTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American71017
White9514
More than one race000
Unknown or Not Reported112
Study Hand VAS
Study Hand VAS(Units on a scale)Treatment Arm With Control OrthosisTreatment Arm With Experimental OrthosisTotal
Mean69.3 ± 18.959.4 ± 20.064.5 ± 19.8
08

Study locations

2 sites
  • NYU Langone
    New York, New York 10016, United States
  • Michael E. DeBakey VA Medical Center
    Houston, Texas 77030, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · May 6, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — Data from this study may be requested from other researchers 3 years after the completion of the primary endpoint by contacting Dr. Grace Lo.

Supporting information: Icf

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04784065
Lead sponsor
Baylor College of Medicine
Collaborators
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Responsible party
Grace Hsiao-Wei Lo (Associate Professor, Baylor College of Medicine) — Principal investigator
First posted
Mar 5, 2021
Start date
Feb 11, 2021
Primary completion
Apr 1, 2024
Completion
Apr 1, 2024
Results posted
Aug 28, 2025
Last update
Aug 28, 2025

Study contacts

Grace H Lo, MD MSc
principal investigator · Baylor College of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion